TDOC— Teladoc Health, Inc.

Health Care$1.3B mkt cap

Metric	FY2020	FY2019	FY2018	FY2018
Revenue	$1.09B+97.7%	$553.3M+32.4%	$417.9M+276.6%	$111.0M
Cost of revenue (exclusive of depreciation and amortization, which is shown separately below)	$390.8M+111.9%	$184.5M+43.3%	$128.7M	—
Advertising and marketing	$226.1M+106.2%	$109.7M+28.9%	$85.1M+292.8%	$21.7M
Sales	$154.1M+137.3%	$64.9M+9.7%	$59.2M+262.8%	$16.3M
Technology and development	$164.9M+155.2%	$64.6M+18.9%	$54.4M+300.5%	$13.6M
Legal and regulatory	$8.9M+31.3%	$6.8M+69.9%	$4.0M	—
Acquisition and integration related costs	$88.2M+1232.9%	$6.6M-36.3%	$10.4M+554.3%	$1.6M
Gain on sale	$0	$0+100.0%	-$5.5M-35.1%	-$4.1M
General and administrative	$497.8M+215.7%	$157.7M+34.9%	$116.9M+285.7%	$30.3M
Depreciation and amortization	$69.5M+78.4%	$39.0M+9.4%	$35.6M+265.3%	$9.7M
Total expenses	$1.60B+152.5%	$633.7M+29.7%	$488.8M	—
Loss from operations	-$506.4M-529.5%	-$80.4M-13.5%	-$70.9M-349.1%	-$15.8M
Loss on extinguishment of debt	$9.1M	$0	$0	—
Interest expense, net	$60.5M+108.5%	$29.0M+11.1%	$26.1M+240.6%	$7.7M
Net loss before taxes	-$576.0M-426.2%	-$109.5M-12.9%	-$97.0M-313.6%	-$23.4M
Income tax (benefit) expense	-$90.9M-757.9%	-$10.6M-9075.4%	$118K+165.6%	-$180K
Net loss	-$485.1M-390.7%	-$98.9M-1.8%	-$97.1M-317.3%	-$23.3M
Net loss per share, basic and diluted	-$5360.00-288.4%	-$1380.00+6.1%	-$1470.00-432252.9%	-$0.34
Weighted-average shares used to compute basic and diluted net loss per share	$90509229000.00+26.0%	$71844535000.00+9.1%	$65844908000.00+96378.9%	$68248000.00

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 13 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.